Technical Advances and Clinical Applications of Quantitative Myocardial Blood Flow Imaging With Cardiac MRI

Progress in Cardiovascular Diseases

Volumn 57, Issue 6, 2015, Pages 615-622

  Heydari, Bobak ^a   Kwong, Raymond Y ^a   Jerosch Herold, Michael ^a  

^a NONE

Author keywords

Cardiac magnetic resonance imaging; Coronary artery disease; Coronary flow reserve; Fractional flow reserve; Ischemia; Myocardial flow reserve; Myocardial infarction; Perfusion; Quantitative myocardial perfusion

Indexed keywords

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY BLOOD FLOW; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; MEASUREMENT PRECISION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROGNOSTIC ASSESSMENT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIATION SAFETY; RADIOCARDIOGRAPHY; FRACTIONAL FLOW RESERVE; HEART DISEASES; IMAGE PROCESSING; MYOCARDIAL PERFUSION IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; THREE DIMENSIONAL IMAGING; TRENDS;

CORONARY CIRCULATION; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART DISEASES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84930042407     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.02.003     Document Type: Article

References (54)

1. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
2. De Bruyne B., Fearon W.F., Pijls N.H., et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014, 371:1208-1217.
3. Korosoglou G., Elhmidi Y., Steen H., et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 2010, 56:1225-1234.
4. Hamon M., Fau G., Nee G., Ehtisham J., Morello R., Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010, 12:29.
5. Greenwood J.P., Maredia N., Younger J.F., et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012, 379:453-460.
6. Shah R., Heydari B., Coelho-Filho O., et al. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation 2013, 128:605-614.
7. Karamitsos T.D., Dall'armellina E., Choudhury R.P., Neubauer S. Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance. Am Heart J 2011, 162:16-30.
8. Miller C.D., Case L.D., Little W.C., et al. Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. J Am Coll Cardiol Img 2013, 6:785-794.
9. Iwata K., Ogasawara K. Comparison of the cost-effectiveness of stress myocardial perfusion MRI and SPECT in patients with suspected coronary artery disease. Radiol Phys Technol 2013, 6:28-34.
10. Francis S.A., Daly C., Heydari B., Abbasi S., Shah R.V., Kwong R.Y. Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2013, 15:52.
11. Walker S., Girardin F., McKenna C., et al. Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 2013, 99:873-881.
12. Duncker D.J., Koller A., Merkus D., Canty J.M. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis 2015, 57(5):409-422.
13. Fearon W.F., Balsam L.B., Farouque H.M., et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003, 107:3129-3132.
14. Gould K.L., Kirkeeide R.L., Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990, 15:459-474.
15. Geldof M.J., Schalij M.J., Manger Cats V., et al. Comparison between regional myocardial perfusion reserve and coronary flow reserve in the canine heart. Eur Heart J 1995, 16:1860-1871.
16. Jerosch-Herold M, Swingen C, Seethamraju RT Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 2002, 29:886-897.
17. Kuijpers D., Janssen C.H., van Dijkman P.R., Oudkerk M. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol 2004, 14:1823-1828.
18. Bartunek J., Wijns W., Heyndrickx G.R., de Bruyne B. Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine. Circulation 1999, 100:243-249.
19. Vasu S., Bandettini W.P., Hsu L.Y., et al. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole-a study of first pass quantitative perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2013, 15:85.
20. Wahl A., Paetsch I., Gollesch A., et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004, 25:1230-1236.
21. Nguyen K.L., Bandettini W.P., Shanbhag S., Leung S.W., Wilson J.R., Arai A.E. Safety and tolerability of regadenoson CMR. Eur Heart J Cardiovasc Imaging 2014, 15:753-760.
22. Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010, 12:57.
23. Klocke F.J., Simonetti O.P., Judd R.M., et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 2001, 104:2412-2416.
24. Nagel E., Klein C., Paetsch I., et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003, 108:432-437.
25. Christian T.F., Aletras A.H., Arai A.E. Estimation of absolute myocardial blood flow during first-pass MR perfusion imaging using a dual-bolus injection technique: comparison to single-bolus injection method. J Magn Reson Imaging 2008, 27:1271-1277.
26. Hautvast G.L., Chiribiri A., Lockie T., Breeuwer M., Nagel E., Plein S. Quantitative analysis of transmural gradients in myocardial perfusion magnetic resonance images. Magn Reson Med 2011, 66:1477-1487.
27. Chiribiri A., Hautvast G.L., Lockie T., et al. Assessment of coronary artery stenosis severity and location: quantitative analysis of transmural perfusion gradients by high-resolution MRI versus FFR. J Am Coll Cardiol Img 2013, 6:600-609.
28. Jerosch-Herold M., Kwong R.Y. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease. Curr Opin Cardiol 2008, 23:599-606.
29. Jerosch-Herold M., Wilke N., Stillman A.E. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998, 25:73-84.
30. Biglands J.D., Magee D.R., Sourbron S.P., Plein S., Greenwood J.P., Radjenovic A. Comparison of the diagnostic performance of four quantitative myocardial perfusion estimation methods used in cardiac MR imaging: CE-MARC substudy. Radiology 2014, 140433. [Epub ahead of print].
31. Lockie T., Ishida M., Perera D., et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2011, 57:70-75.
32. Morton G., Chiribiri A., Ishida M., et al. Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol 2012, 60:1546-1555.
33. Schuster A., Zarinabad N., Ishida M., et al. Quantitative assessment of magnetic resonance derived myocardial perfusion measurements using advanced techniques: microsphere validation in an explanted pig heart system. J Cardiovasc Magn Reson 2014, 16:82.
34. Nekolla S.G., Reder S., Saraste A., et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009, 119:2333-2342.
35. Muzik O., Beanlands R.S., Hutchins G.D., Mangner T.J., Nguyen N., Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993, 34:83-91.
36. Murthy V.L., Naya M., Foster C.R., et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011, 124:2215-2224.
37. Herzog B.A., Husmann L., Valenta I., et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009, 54:150-156.
38. Miller C.A., Naish J.H., Ainslie M.P., et al. Voxel-wise quantification of myocardial blood flow with cardiovascular magnetic resonance: effect of variations in methodology and validation with positron emission tomography. J Cardiovasc Magn Reson 2014, 16:11.
39. Ibrahim T., Nekolla S.G., Schreiber K., et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 2002, 39:864-870.
40. Patel A.R., Antkowiak P.F., Nandalur K.R., et al. Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol 2010, 56:561-569.
41. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002, 105:539-542.
42. Shin T., Nayak K.S., Santos J.M., Nishimura D.G., Hu B.S., McConnell M.V. Three-dimensional first-pass myocardial perfusion MRI using a stack-of-spirals acquisition. Magn Reson Med 2013, 69:839-844.
43. Vitanis V., Manka R., Giese D., et al. High resolution three-dimensional cardiac perfusion imaging using compartment-based k-t principal component analysis. Magn Reson Med 2011, 65:575-587.
44. Manka R., Paetsch I., Kozerke S., et al. Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location. Eur Heart J 2012, 33:2016-2024.
45. Jogiya R., Kozerke S., Morton G., et al. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol 2012, 60:756-765.
46. Motwani M., Kidambi A., Sourbron S., et al. Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole. J Cardiovasc Magn Reson 2014, 16:19.
47. Prince M.R., Zhang H., Morris M., et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 2008, 248:807-816.
48. Adluru G., DiBella E.V., Schabel M.C. Model-based registration for dynamic cardiac perfusion MRI. J Magn Reson Imaging 2006, 24:1062-1070.
49. Stegmann M.B., Olafsdottir H., Larsson H.B. Unsupervised motion-compensation of multi-slice cardiac perfusion MRI. Med Image Anal 2005, 9:394-410.
50. Weng A.M., Ritter C.O., Lotz J., Beer M.J., Hahn D., Kostler H. Automatic postprocessing for the assessment of quantitative human myocardial perfusion using MRI. Eur Radiol 2010, 20:1356-1365.
51. Weng A.M., Ritter C.O., Beer M., Hahn D., Kostler H. Quantitative pixelwise myocardial perfusion maps from first-pass perfusion MRI. Br J Radiol 2014, 87:20130727. 10.1259/bjr.20130727.
52. Cheong B.Y., Muthupillai R., Wilson J.M., et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009, 120:2069-2076.
53. Zemrak F., Petersen S.E. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis 2011, 54:215-229.
54. Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011, 364:1617-1625.